Two cases of focal nodular hyperplasia of the liver: value of scintigraphy with Tc-99m GSA and positron emission tomography with FDG

Ann Nucl Med. 1999 Dec;13(6):427-31. doi: 10.1007/BF03164939.

Abstract

Focal nodular hyperplasia (FNH) of the liver is relatively rare, and can be difficult to differentiate from other benign tumors arising in the liver. We describe a 23-year-old woman and a 25-year-old man with FNH. They were hospitalized for further evaluation of a space-occupying lesion in the liver. Scintigraphy with Tc-99m diethylenetriaminepentaacetic acid galactosyl human serum albumin (Tc-99m GSA) revealed increased radioactivity in the tumor in one patient and radioactivity similar to that in the normal part of liver in the other. F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) showed uptake similar to that of the normal liver in both patients. FNH was diagnosed on the basis of angiographic findings and histological findings in liver biopsy specimens. Our results show that scintigraphy with Tc-99m GSA and FDG-PET may provide information helpful in the diagnosis of FNH.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Biopsy
  • Female
  • Fluorodeoxyglucose F18* / pharmacokinetics
  • Focal Nodular Hyperplasia / diagnostic imaging*
  • Focal Nodular Hyperplasia / pathology
  • Humans
  • Liver / diagnostic imaging*
  • Liver / pathology
  • Male
  • Radiopharmaceuticals* / pharmacokinetics
  • Technetium Tc 99m Aggregated Albumin* / pharmacokinetics
  • Technetium Tc 99m Pentetate* / pharmacokinetics
  • Tissue Distribution
  • Tomography, Emission-Computed
  • Tomography, X-Ray Computed

Substances

  • Radiopharmaceuticals
  • Technetium Tc 99m Aggregated Albumin
  • technetium Tc 99m DTPA-galactosyl-human serum albumin
  • Fluorodeoxyglucose F18
  • Technetium Tc 99m Pentetate